AXQ Capital’s Centessa Pharmaceuticals CNTA Stock Holding History

AXQ Capital’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,303	Closed	-$330K	–	1049
2026 Q1	$330K	Buy	+8,303	New	+$212K	0.04%	567

AXQ Capital's CNTA Position: Q2 2026 in Review

AXQ Capital sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 8,303 shares — an estimated $330K sold.

AXQ Capital first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $330K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

AXQ Capital reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 8,303 Centessa Pharmaceuticals shares in Q2 2026, an estimated $330K.
AXQ Capital first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
AXQ Capital's Centessa Pharmaceuticals position peaked at $330K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.